
The association of zzso and infection continues to be a major cause of morbidity and mortality in cancer patients receiving zzso zzso zzso hospitalization and initiation of empirical intravenous zzso antibiotics has been the standard of care during the past three zzso Recently, zzso models have been developed that allow the identification of zzso zzso patients that are at low risk for medical complications and zzso New treatment strategies are being evaluated in this low-risk patient population to safely reduce zzso decrease costs, and improve quality of zzso These include early shift from intravenous therapy to oral zzso immediate initiation of oral zzso treatment, early hospital zzso or zzso zzso A zzso approach should also be applied to the use of zzso factors in this zzso Growth factors should not be routinely administered to zzso patients with uncomplicated zzso zzso However, recent data support their use in populations with high-risk zzso zzso 

